PCRX Operating Cash Flow (Statement)
Pacira Biosciences Inc · Operating Cash Flow (Statement)
PCRX Operating Cash Flow (Statement)
Latest reported$57.46Mperiod ending
PCRX Quarterly Cash from Operations (-$9.94M → $57.46M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
PCRX operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 57,460,000 | |
| 25,680,000 | |
| 43,689,000 | |
| 60,834,000 | |
| 12,012,000 | |
| 35,459,000 | |
| 33,132,000 | |
| 53,920,000 | |
| 53,236,000 | |
| 49,101,000 | |
| 47,584,000 | |
| 44,438,000 | |
| 43,499,000 | |
| 19,128,000 | |
| 42,037,000 | |
| 42,654,000 | |
| 29,806,000 | |
| 30,777,000 | |
| 23,215,000 | |
| 60,287,000 | |
| 30,134,000 | |
| 12,081,000 | |
| 46,667,000 | |
| 39,781,000 | |
| -15,624,000 | |
| 6,208,000 | |
| 25,904,000 | |
| 18,354,000 | |
| 22,763,000 | |
| 3,499,000 | |
| 21,220,000 | |
| 16,629,000 | |
| 13,710,000 | |
| -2,689,000 | |
| 16,931,000 | |
| -2,808,000 | |
| 3,656,000 | |
| 6,000 | |
| 17,349,000 | |
| 11,684,000 | |
| 7,541,000 | |
| -3,121,000 | |
| 17,035,000 | |
| 2,817,000 | |
| 8,651,000 | |
| 493,000 | |
| 13,011,000 | |
| 8,976,000 | |
| 8,218,000 | |
| -4,736,000 | |
| -6,280,000 | |
| -9,837,000 | |
| -13,310,000 | |
| -13,789,000 | |
| -21,179,000 | |
| -11,177,000 | |
| -20,229,000 | |
| -17,545,000 | |
| -7,596,000 | |
| -8,494,000 | |
| -10,923,000 | |
| -3,987,000 | |
| -5,840,000 | |
| -6,913,000 | |
| -8,531,000 | |
| -3,596,000 | |
| 839,000 | |
| -9,940,000 |